Isabelle Rault

发表

First-Line Afatinib plus Cetuximab for EGFR-Mutant Non–Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study

O. Molinier, M. Denis, D. Moro-Sibilot, 2021, Clinical Cancer Research.